1. Home
  2. MIRA vs SVRE Comparison

MIRA vs SVRE Comparison

Compare MIRA & SVRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIRA
  • SVRE
  • Stock Information
  • Founded
  • MIRA 2020
  • SVRE 2014
  • Country
  • MIRA United States
  • SVRE Israel
  • Employees
  • MIRA N/A
  • SVRE N/A
  • Industry
  • MIRA Biotechnology: Pharmaceutical Preparations
  • SVRE
  • Sector
  • MIRA Health Care
  • SVRE
  • Exchange
  • MIRA Nasdaq
  • SVRE Nasdaq
  • Market Cap
  • MIRA 10.2M
  • SVRE 6.6M
  • IPO Year
  • MIRA 2023
  • SVRE 2022
  • Fundamental
  • Price
  • MIRA $2.36
  • SVRE $0.32
  • Analyst Decision
  • MIRA
  • SVRE
  • Analyst Count
  • MIRA 0
  • SVRE 0
  • Target Price
  • MIRA N/A
  • SVRE N/A
  • AVG Volume (30 Days)
  • MIRA 11.4M
  • SVRE 338.9K
  • Earning Date
  • MIRA 09-13-2024
  • SVRE 08-27-2024
  • Dividend Yield
  • MIRA N/A
  • SVRE N/A
  • EPS Growth
  • MIRA N/A
  • SVRE N/A
  • EPS
  • MIRA N/A
  • SVRE N/A
  • Revenue
  • MIRA N/A
  • SVRE $2,720,000.00
  • Revenue This Year
  • MIRA N/A
  • SVRE $219.30
  • Revenue Next Year
  • MIRA N/A
  • SVRE $148.59
  • P/E Ratio
  • MIRA N/A
  • SVRE N/A
  • Revenue Growth
  • MIRA N/A
  • SVRE 331.06
  • 52 Week Low
  • MIRA $0.51
  • SVRE $0.26
  • 52 Week High
  • MIRA $6.95
  • SVRE $1.50
  • Technical
  • Relative Strength Index (RSI)
  • MIRA 59.37
  • SVRE 35.70
  • Support Level
  • MIRA $0.62
  • SVRE $0.31
  • Resistance Level
  • MIRA $5.01
  • SVRE $0.40
  • Average True Range (ATR)
  • MIRA 0.57
  • SVRE 0.04
  • MACD
  • MIRA 0.26
  • SVRE 0.00
  • Stochastic Oscillator
  • MIRA 41.07
  • SVRE 11.22

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

About SVRE SaverOne 2014 Ltd.

Saverone 2014 Ltd provides driver protection solutions. The company develops and deploys ADAS technologies for transportation safety and driver assistance. The company's product restricts the driver from surfing, communicating, and receiving alerts while driving. The Company has developed a system that provides a solution to the problem of distracted driving caused by cell phone use, which endangers the driver, passengers, other drivers on the road, and pedestrians.

Share on Social Networks: